Hostname: page-component-74656f9884-c52kr Total loading time: 0 Render date: 2026-11-08T10:41:09.141Z Has data issue: false hasContentIssue false

Modified arytenoid adduction for cancer-related unilateral vocal fold paralysis

Published online by Cambridge University Press:  25 November 2010

J Shi
Affiliation:
Department of Otorhinolaryngology–Head and Neck Surgery, Changhai Hospital, Second Military Medical University, Shanghai, China
S Chen
Affiliation:
Department of Otorhinolaryngology–Head and Neck Surgery, Changhai Hospital, Second Military Medical University, Shanghai, China
D Chen
Affiliation:
Department of Otorhinolaryngology–Head and Neck Surgery, Changhai Hospital, Second Military Medical University, Shanghai, China
W Wang
Affiliation:
Department of Otorhinolaryngology–Head and Neck Surgery, Changhai Hospital, Second Military Medical University, Shanghai, China
S Xia
Affiliation:
Department of Otorhinolaryngology–Head and Neck Surgery, Changhai Hospital, Second Military Medical University, Shanghai, China
H Zheng*
Affiliation:
Department of Otorhinolaryngology–Head and Neck Surgery, Changhai Hospital, Second Military Medical University, Shanghai, China
*
Address for correspondence: Dr Hongliang Zheng, Department of Otorhinolaryngology–Head and Neck Surgery, Changhai Hospital, Second Military Medical University, Changhai Road 168, Shanghai 200433, China Fax: +86 21 65335025 E-mail: zheng_hl2004@163.com
Rights & Permissions [Opens in a new window]

Abstract

Objectives:

(1) To evaluate the efficacy of modified arytenoid adduction in the management of patients with symptomatic cancer-related unilateral vocal fold paralysis, and (2) to assess the impact of this treatment on patients' quality of life.

Methods:

Forty-two patients with cancer-related unilateral vocal fold paralysis underwent modified arytenoid adduction between February 2001 and December 2008. Of these, 37 patients were enrolled in this retrospective study (one patient died of primary disease and four were lost to follow up). Laryngostroboscopy was performed to evaluate vocal fold orientation and mobility. Pre- and post-operative assessment of subjective and objective voice, aerodynamic parameters, and quality of life were also undertaken, and aspiration was subjectively rated.

Results:

Laryngostroboscopic findings indicated a significant post-operative improvement in vocal fold posterior glottal closure and vertical gap. Significant improvements in voice quality, aerodynamic parameters and quality of life were noted three months post-operatively in all patients (p < 0.01). The overall success rate for swallowing rehabilitation was 94.6 per cent (35/37). Subjective aspiration ratings decreased significantly post-operatively, compared with pre-operative values (p < 0.01). No major complication occurred in any patient, except for dyspnoea in one patient.

Conclusion:

Modified arytenoid adduction is an effective and reliable medialisation technique which can restore satisfactory voice quality, prevent aspiration and lead to a better quality of life for patients with cancer-related unilateral vocal fold paralysis.

Information

Type
Main Articles
Copyright
Copyright © JLO (1984) Limited 2010
Figure 0

Fig. 1 Modified arytenoid adduction technique for a representative case with left unilateral vocal fold paralysis. Black asterisk indicates the inferior cornu of the thyroid cartilage. (a) After incising the inferior pharyngeal constrictor and dragging anteriorly the posterior margin of the thyroid cartilage, the inferior cornu of the thyroid cartilage and the muscular process of the arytenoid are exposed. (b) Two prolene sutures are placed through the muscular process of the arytenoid, leaving four long tails for adduction. (c) Traction placed on the arytenoid-thyroid cartilage suture rotates the vocal process medially, but leads to detachment of the articular facet between the arytenoid and cricoid. (d) The second suture is attached to the cornu posterior cricoid ligament; traction on this suture relocates the arytenoid to approximate the physiological adduction position. CI = inferior cornu of thyroid cartilage; PM = posterior margin of thyroid cartilage; MP = muscular process of arytenoid; RLN = recurrent laryngeal nerve; SLN = superior laryngeal nerve

Figure 1

Fig. 2 Laryngostroboscopic findings for a representative case of cancer-related unilateral vocal fold paralysis, before and three months after modified arytenoid adduction: (a) pre-operative, inhalation; (b) pre-operative, phonation; (c) post-operative, inhalation; (d) post-operative, phonation. A significant post-operative improvement in posterior glottal closure is seen, with no obvious gap between the two vocal folds during phonation.

Figure 2

Table I Nonparametric analysis of grbas scale assessment: pre- vs post-operative

Figure 3

Table II Acoustic and aerodynamic analyses

Figure 4

Table III SF-36 scores

Figure 5

Table IV VHI and VOS scores